RT @matheos33: @PBasiukiewicz To ja dam takie: Leczenie nadciśnienia niekoniecznie się opłaca: https://t.co/WXHhxAap8U https://t.co/JR30BTJ…
@PBasiukiewicz To ja dam takie: Leczenie nadciśnienia niekoniecznie się opłaca: https://t.co/WXHhxAap8U https://t.co/JR30BTJKEk
@PBasiukiewicz Ciekawostka. Na Cochrane można znaleźć analizy że obniżanie łagodnego nadciśnienia lub nadciśnienia u osob do 59 roku życia może nie mieć sensu.https://t.co/JR30BTJKEk
RT @CochraneHTN: Day 5🎄#HTN12daysEBM☃️ Who benefits from #HTN treatment?🤔 Treating #hypertension generally↘️one's risks The🔝benefit for t…
RT @CochraneHTN: Day 5🎄#HTN12daysEBM☃️ Who benefits from #HTN treatment?🤔 Treating #hypertension generally↘️one's risks The🔝benefit for t…
RT @CochraneHTN: Day 5🎄#HTN12daysEBM☃️ Who benefits from #HTN treatment?🤔 Treating #hypertension generally↘️one's risks The🔝benefit for t…
RT @CochraneHTN: Day 5🎄#HTN12daysEBM☃️ Who benefits from #HTN treatment?🤔 Treating #hypertension generally↘️one's risks The🔝benefit for t…
RT @CochraneHTN: Day 5🎄#HTN12daysEBM☃️ Who benefits from #HTN treatment?🤔 Treating #hypertension generally↘️one's risks The🔝benefit for t…
Day 5🎄#HTN12daysEBM☃️ Who benefits from #HTN treatment?🤔 Treating #hypertension generally↘️one's risks The🔝benefit for treatment appears to come in ppl aged 60-80, but lower🎯likely aren't needed See: https://t.co/JgLSrjGkP6 + https://t.co/nWY7xFOjj8 #p
5/13 WHO benefits from TREATMENT❓🤔 Treating #hypertension generally ↘️ one's risks The⬆️ benefit for treatment appears to come in 👨👩🏾 aged 60-80, but lower targets aren’t likely necessary https://t.co/JgLSrjGkP6 and https://t.co/nWY7xFOjj8 #HTNevidence
5/13 WHO benefits from TREATMENT❓🤔 Treating #hypertension generally ↘️ one's risks The ⬆️ benefit for treatment appears to come in 👨🏽🧕🏻aged 60-80. but ↘️ targets aren’t likely necessary https://t.co/TmtZHWKZOb and https://t.co/0OOi24yJmr #HTNevidence #
RT @DrRitaMc: Hypertension treatment NOT the secret to immortality? What the what? 😱 This @CochraneHTN review shows little benefit (or none…
RT @DrRitaMc: Hypertension treatment NOT the secret to immortality? What the what? 😱 This @CochraneHTN review shows little benefit (or none…
RT @DrRitaMc: Hypertension treatment NOT the secret to immortality? What the what? 😱 This @CochraneHTN review shows little benefit (or none…
RT @DrRitaMc: Hypertension treatment NOT the secret to immortality? What the what? 😱 This @CochraneHTN review shows little benefit (or none…
RT @DrRitaMc: Hypertension treatment NOT the secret to immortality? What the what? 😱 This @CochraneHTN review shows little benefit (or none…
RT @AKECassels: Let's not forget the possible harms of overtreating hypertension: hypotension in the elderly a real problem... @Drug_Eviden…
RT @LessIsMoreMed: The beginning of the end of medicine?! https://t.co/0sl6zpsFhA
RT @AKECassels: Let's not forget the possible harms of overtreating hypertension: hypotension in the elderly a real problem... @Drug_Eviden…
RT @AKECassels: Let's not forget the possible harms of overtreating hypertension: hypotension in the elderly a real problem... @Drug_Eviden…
RT @AKECassels: Let's not forget the possible harms of overtreating hypertension: hypotension in the elderly a real problem... @Drug_Eviden…
RT @AKECassels: Let's not forget the possible harms of overtreating hypertension: hypotension in the elderly a real problem... @Drug_Eviden…
RT @DrRitaMc: Hypertension treatment NOT the secret to immortality? What the what? 😱 This @CochraneHTN review shows little benefit (or none…
RT @AKECassels: Let's not forget the possible harms of overtreating hypertension: hypotension in the elderly a real problem... @Drug_Eviden…
RT @DrRitaMc: Hypertension treatment NOT the secret to immortality? What the what? 😱 This @CochraneHTN review shows little benefit (or none…
RT @DrRitaMc: Hypertension treatment NOT the secret to immortality? What the what? 😱 This @CochraneHTN review shows little benefit (or none…
RT @DrRitaMc: Hypertension treatment NOT the secret to immortality? What the what? 😱 This @CochraneHTN review shows little benefit (or none…
RT @LessIsMoreMed: The beginning of the end of medicine?! https://t.co/0sl6zpsFhA
RT @DrRitaMc: Hypertension treatment NOT the secret to immortality? What the what? 😱 This @CochraneHTN review shows little benefit (or none…
RT @DrRitaMc: Hypertension treatment NOT the secret to immortality? What the what? 😱 This @CochraneHTN review shows little benefit (or none…
RT @DrRitaMc: Hypertension treatment NOT the secret to immortality? What the what? 😱 This @CochraneHTN review shows little benefit (or none…
RT @LessIsMoreMed: The beginning of the end of medicine?! https://t.co/0sl6zpsFhA
The beginning of the end of medicine?! https://t.co/0sl6zpsFhA
RT @amtejani: #Drugevidence Even the stroke reduction is based on low/very low quality evidence. I think we need to find a way to provide t…
RT @AKECassels: Let's not forget the possible harms of overtreating hypertension: hypotension in the elderly a real problem... @Drug_Eviden…
#Drugevidence Even the stroke reduction is based on low/very low quality evidence. I think we need to find a way to provide the results of this review to patients so they can make an informed decision. https://t.co/W2KI5E7cEk
RT @DrRitaMc: Hypertension treatment NOT the secret to immortality? What the what? 😱 This @CochraneHTN review shows little benefit (or none…
Let's not forget the possible harms of overtreating hypertension: hypotension in the elderly a real problem... @Drug_Evidence @DrRitaMc @LessIsMoreMed @amtejani @CaitO_PharmD https://t.co/G7d2NWAm0k
RT @DrRitaMc: Hypertension treatment NOT the secret to immortality? What the what? 😱 This @CochraneHTN review shows little benefit (or none…
But I thought hypertension was the silent killer? I'm so confused. https://t.co/llWYXXstyf
RT @DrRitaMc: Hypertension treatment NOT the secret to immortality? What the what? 😱 This @CochraneHTN review shows little benefit (or none…
Hypertension treatment NOT the secret to immortality? What the what? 😱 This @CochraneHTN review shows little benefit (or none), on all outcomes. Clinical relevance? #DrugEvidence @amtejani @AKECasselsance @LessIsMoreMed @Drug_Evidence @CaitO_PharmD htt
RT @rincondesisifo: (Cochrane) Farmacoterapia de la HTA en pac entre 18-59 años https://t.co/msKFCpxGpv ↓morbimortalidad CV pero no la de o…
RT @rincondesisifo: (Cochrane) Farmacoterapia de la HTA en pac entre 18-59 años https://t.co/msKFCpxGpv ↓morbimortalidad CV pero no la de o…
RT @rincondesisifo: (Cochrane) Farmacoterapia de la HTA en pac entre 18-59 años https://t.co/msKFCpxGpv ↓morbimortalidad CV pero no la de o…
RT @rincondesisifo: (Cochrane) Farmacoterapia de la HTA en pac entre 18-59 años https://t.co/msKFCpxGpv ↓morbimortalidad CV pero no la de o…
(Cochrane) Farmacoterapia para la hipertensión en adultos de 18 a 59 años de edad. https://t.co/vPtSWCUsPP
RT @rincondesisifo: (Cochrane) Farmacoterapia de la HTA en pac entre 18-59 años https://t.co/msKFCpxGpv ↓morbimortalidad CV pero no la de o…
(Cochrane) Farmacoterapia de la HTA en pac entre 18-59 años https://t.co/msKFCpxGpv ↓morbimortalidad CV pero no la de origen coronario ni la mortalidad por cualquier causa
RT @KFSHRC_Research: Pharmacotherapy for #hypertension in adults aged 18 to 59 years https://t.co/PPkIbdGOa8 https://t.co/igZLWtyGy4
RT @KFSHRC_Research: Pharmacotherapy for #hypertension in adults aged 18 to 59 years https://t.co/PPkIbdGOa8 https://t.co/igZLWtyGy4
RT @KFSHRC_Research: Pharmacotherapy for #hypertension in adults aged 18 to 59 years https://t.co/PPkIbdGOa8 https://t.co/igZLWtyGy4
RT @KFSHRC_Research: Pharmacotherapy for #hypertension in adults aged 18 to 59 years https://t.co/PPkIbdGOa8 https://t.co/igZLWtyGy4
Pharmacotherapy for #hypertension in adults aged 18 to 59 years https://t.co/PPkIbdGOa8 https://t.co/igZLWtyGy4
RT @DanielSimancasR: Tratamiento de la HTA en adultos entre 18 y 59 años. 7 ensayos clínicos 17 mil pacientes @rhidalgott @paomorejon @xmor…
Treatment for hypertension in adults aged 18 to 59 years https://t.co/TefTxAqJpm
El tratamiento de la hipertensión arterial en adultos entre 18 y 59 años parece tener un efecto muy pequeño o... https://t.co/qZ6SFao2PU
RT @DanielSimancasR: Tratamiento de la HTA en adultos entre 18 y 59 años. 7 ensayos clínicos 17 mil pacientes @rhidalgott @paomorejon @xmor…
Tratamiento de la HTA en adultos entre 18 y 59 años. 7 ensayos clínicos 17 mil pacientes @rhidalgott @paomorejon @xmoralesh @camilo_felix https://t.co/bwAFq6pnGf
RT @pass_paces: RT @CochraneUK: Treatment for hypertension in adults aged 18 to 59 years - what's the evidence? https://t.co/pH0tZzzUVP
RT @CochraneUK: Treatment for hypertension in adults aged 18 to 59 years - what's the evidence? https://t.co/pH0tZzzUVP
RT @alfonso_casi: Farmacoterapia para la hipertensión en adultos de 18 a 59 años, revisión Cochrane. https://t.co/gb44JS5Iya
Farmacoterapia para la hipertensión en adultos de 18 a 59 años, revisión Cochrane. https://t.co/gb44JS5Iya
RT @Actual_clinica: Tratamiento para la hipertensión en adultos de 18 a 59 años de edad Cochrane https://t.co/L19G5YDJpk
RT @Actual_clinica: Tratamiento para la hipertensión en adultos de 18 a 59 años de edad Cochrane https://t.co/L19G5YDJpk
RT @Actual_clinica: Tratamiento para la hipertensión en adultos de 18 a 59 años de edad Cochrane https://t.co/L19G5YDJpk
Segons això també podríem tractar els hipertensos amb homeopatia...0_o https://t.co/uFbe7cJqjT
RT @Actual_clinica: Tratamiento para la hipertensión en adultos de 18 a 59 años de edad Cochrane https://t.co/L19G5YDJpk
Tratamiento para la hipertensión en adultos de 18 a 59 años de edad Cochrane https://t.co/L19G5YDJpk
Pharmacotherapy for hypertension in adults aged 18 to 59 years https://t.co/eoazzcqJhI
RT @lugifel: Cochrane: Antihipertensivos en adultos sanos (18-59 años) con HTA leve-moderada no disminuyen mortalidad total https://t.co/13…
RT @lugifel: Cochrane: Antihipertensivos en adultos sanos (18-59 años) con HTA leve-moderada no disminuyen mortalidad total https://t.co/13…
RT @lugifel: Cochrane: Antihipertensivos en adultos sanos (18-59 años) con HTA leve-moderada no disminuyen mortalidad total https://t.co/13…
Cochrane: Antihipertensivos en adultos sanos (18-59 años) con HTA leve-moderada no disminuyen mortalidad total https://t.co/13p3koA2vi
Antihypertensive drugs for healthy adults (18 to 59 y) with mild to moderate HT does not change all-cause mortality https://t.co/60gpaXoiLI
Pharmacotherapy for hypertension in adults aged 18 to 59 years. - PubMed - NCBI https://t.co/KNYfHrWFeu
Pharmacotherapy for hypertension in adults aged 18 to 59 years https://t.co/BWIqX3CHNN
RT @cochrane_nz: Read the evidence on the treatment for #hypertension in adults aged 18 to 59 years https://t.co/8actX4bwMY https://t.co/4Y…
RT @cochrane_nz: Read the evidence on the treatment for #hypertension in adults aged 18 to 59 years https://t.co/8actX4bwMY https://t.co/4Y…
Read the evidence on the treatment for #hypertension in adults aged 18 to 59 years https://t.co/8actX4bwMY https://t.co/4YDacTuflH
RT @CochraneHTN: NEW #Cochrane review: Pharmacotherapy for hypertension in adults aged 18 to 59: https://t.co/ABk9HNBZPC #CochraneEvidence…
NEW #Cochrane review: Pharmacotherapy for hypertension in adults aged 18 to 59: https://t.co/ABk9HNBZPC #CochraneEvidence @cochranecollab https://t.co/KuFAvOBFzM
Treatment for hypertension in adults aged 18 to 59 years https://t.co/1BAsWTQ4LZ
CochraneLibrary: Treatment for hypertension in adults aged 18 to 59 years https://t.co/zT7MRS8p7f https://t.co/3Xs9zCV5zO
NEW #Cochrane review: Pharmacotherapy for hypertension in adults aged 18 to 59: https://t.co/7MbVt6jKTt #CochraneEvidence @CochraneLibrary https://t.co/tuqhH7vTo5
"The Cochrane database of systematic reviews"[Journal] OR "The Cochrane library"[Journal… https://t.co/BoVX6F3QQC